Unexpected Atypical Findings on CT after Radiofrequency Ablation for Small Renal-cell Carcinoma and the Role of Percutaneous Biopsy

Journal of Vascular and Interventional Radiology

Volumn 18, Issue 9, 2007, Pages 1186-1191

  Javadi, Sanaz ^a   Matin, Surena F ^a   Tamboli, Pheroze ^a   Ahrar, Kamran ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM;

ARTICLE; CANCER PATIENT; CASE REPORT; CHRONIC INFLAMMATION; COMPUTER ASSISTED TOMOGRAPHY; FAT NECROSIS; HUMAN; HUMAN TISSUE; INFLAMMATION; KIDNEY CARCINOMA; KIDNEY NECROSIS; PERCUTANEOUS BIOPSY; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; SMALL CELL CARCINOMA;

AGED; BIOPSY, NEEDLE; CARCINOMA, RENAL CELL; CATHETER ABLATION; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; NEOPLASM RECURRENCE, LOCAL; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 34548242727     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvir.2007.06.019     Document Type: Article

References (14)

1. Chow W.H., Devesa S.S., Warren J.L., and Fraumeni Jr. J.F. Rising incidence of renal cell cancer in the United States. JAMA 281 (1999) 1628-1631
2. Jayson M., and Sanders H. Increased incidence of serendipitously discovered renal cell carcinoma. Urology 51 (1998) 203-205
3. Ahrar K., Wallace M.J., and Matin S.F. Percutaneous radiofrequency ablation: minimally invasive therapy for renal tumors. Expert Rev Anticancer Ther 6 (2006) 1735-1744
4. Goldberg S.N., Gazelle G.S., Compton C.C., Mueller P.R., and Tanabe K.K. Treatment of intrahepatic malignancy with radiofrequency ablation: radiologic-pathologic correlation. Cancer 88 (2000) 2452-2463
5. Gervais D.A., McGovern F.J., Wood B.J., Goldberg S.N., McDougal W.S., and Mueller P.R. Radio-frequency ablation of renal cell carcinoma: early clinical experience. Radiology 217 (2000) 665-672
6. Merkle E.M., Nour S.G., and Lewin J.S. MR imaging follow-up after percutaneous radiofrequency ablation of renal cell carcinoma: findings in 18 patients during first 6 months. Radiology 235 (2005) 1065-1071
7. Gervais D.A., Arellano R.S., McGovern F.J., McDougal W.S., and Mueller P.R. Radiofrequency ablation of renal cell carcinoma: part 2, lessons learned with ablation of 100 tumors. AJR Am J Roentgenol 185 (2005) 72-80
8. Gervais D.A., McGovern F.J., Arellano R.S., McDougal W.S., and Mueller P.R. Radiofrequency ablation of renal cell carcinoma: part 1, indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. AJR Am J Roentgenol 185 (2005) 64-71
9. Farrell M.A., Charboneau W.J., DiMarco D.S., et al. Imaging-guided radiofrequency ablation of solid renal tumors. AJR Am J Roentgenol 180 (2003) 1509-1513
10. Matin S.F., Ahrar K., Cadeddu J.A., et al. Residual and recurrent disease following renal energy ablative therapy: a multi-institutional study. J Urol 176 (2006) 1973-1977
11. Silverman S.G., Gan Y.U., Mortele K.J., Tuncali K., and Cibas E.S. Renal masses in the adult patient: the role of percutaneous biopsy. Radiology 240 (2006) 6-22
12. Johnson P.T., Nazarian L.N., Feld R.I., et al. Sonographically guided renal mass biopsy: indications and efficacy. J Ultrasound Med 20 (2001) 749-753
13. Rybicki F.J., Shu K.M., Cibas E.S., Fielding J.R., vanSonnenberg E., and Silverman S.G. Percutaneous biopsy of renal masses: sensitivity and negative predictive value stratified by clinical setting and size of masses. AJR Am J Roentgenol 180 (2003) 1281-1287
14. Zardawi I.M. Renal fine needle aspiration cytology. Acta Cytol 43 (1999) 184-190